Stay updated on T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 was added to the study record history, while the previous revision v3.6.5 is removed from the list; this reflects an update to the page's versioning metadata in the history.
    Difference
    0.1%
    Check dated 2026-08-29T19:08:58.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The study page's revision history shows a new Revision: v3.6.5, replacing v3.6.4. This reflects a software release update to the ClinicalTrials.gov page rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-08-08T19:12:37.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 appears in the study record history, and Revision: v3.6.3 is removed. This update reflects an update to the record's version history.
    Difference
    0.1%
    Check dated 2026-07-25T10:51:30.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A new page revision is recorded (v3.6.3) replacing the earlier revision (v3.6.2) in the study's history. This reflects an update to the page metadata rather than substantive study details.
    Difference
    0.1%
    Check dated 2026-07-03T23:51:51.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The revision history now shows a new entry for v3.6.2, replacing the prior v3.6.0 in the study record.
    Difference
    0.1%
    Check dated 2026-06-26T20:25:33.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    Recruitment status was updated to 'No longer looking for participants', indicating enrollment has ended. The record history was updated to Revision: v3.6.0, replacing the previous revision (v3.5.5).
    Difference
    0.7%
    Check dated 2026-06-12T16:09:36.000Z thumbnail image

Stay in the know with updates to T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.